Incorporating intensity modulated total body irradiation into a Children's Oncology Group trial: Rationale, techniques, and safeguards

Abstract

AbstractHistorically, total body irradiation (TBI) has been delivered using static, parallel opposed photon beams (2D‐TBI). Recently, centers have increasingly used intensity‐modulated radiation therapy (IMRT) techniques for TBI. Relative to 2D‐TBI, IMRT can reduce doses to critical organs (i.e., lungs and kidneys) while delivering myeloablative doses to the rest of the body, so it may decrease the risk of toxicity while maintaining oncologic outcomes. Despite these potential benefits, delivering TBI using IMRT introduces new challenges in treatment planning and delivery. We describe the extensive experience with IMRT‐based TBI at Stanford University and City of Hope Cancer Center. These groups, and others, have reported favorable clinical outcomes and have developed methods to optimize treatment planning and delivery. A critical next step is to evaluate the broader adoption of this approach. Therefore, IMRT‐based TBI will be incorporated into a prospective, multi‐institutional Children's Oncology Group study with careful procedures and safeguards in place.